HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles J Czuprynski Selected Research

3-(2-phenylethyl)-4-methylsydnone

10/2016Interfacial Stacks of Polymeric Nanofilms on Soft Biological Surfaces that Release Multiple Agents.
10/2012Polymeric multilayers that localize the release of chlorhexidine from biologic wound dressings.
8/2012Antibacterial efficacy of silver-impregnated polyelectrolyte multilayers immobilized on a biological dressing in a murine wound infection model.
5/2011Polymeric Multilayers that contain Silver Nanoparticles can be Stamped onto Biological Tissues to Provide Antibacterial Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles J Czuprynski Research Topics

Disease

11Wounds and Injuries (Trauma)
03/2022 - 02/2010
10Infections
03/2022 - 08/2003
4Inflammation (Inflammations)
01/2022 - 03/2013
3Listeriosis (Listeria Infection)
03/2013 - 08/2003
2Paratuberculosis (Johne's Disease)
01/2011 - 09/2009
2Sepsis (Septicemia)
02/2008 - 10/2005
1Coinfection
09/2013
1Necrosis
01/2013
1Wound Infection (Wound Infections)
08/2012
1Burns
08/2012
1Bovine Respiratory Disease Complex
11/2010
1Animal Diseases
11/2008
1Thrombosis (Thrombus)
10/2007
1Central Nervous System Infections (Central Nervous System Infection)
10/2007
1Bacterial Infections (Bacterial Infection)
12/2004
1Neoplasms (Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
09/2018 - 10/2012
4CollagenIBA
09/2018 - 10/2012
43-(2-phenylethyl)-4-methylsydnoneIBA
10/2016 - 05/2011
4SilverIBA
06/2014 - 02/2010
3FibrinIBA
01/2022 - 11/2010
3Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
11/2009 - 11/2007
3CytokinesIBA
10/2009 - 10/2005
2Peptides (Polypeptides)IBA
03/2022 - 10/2012
2Interleukin-8 (Interleukin 8)IBA
09/2013 - 10/2009
2BiobraneIBA
10/2012 - 08/2012
1Biocompatible Materials (Biomaterials)IBA
12/2015
1hydroxide ionIBA
12/2015
1Tryptophan (L-Tryptophan)FDA Link
11/2015
1Anti-Infective Agents (Microbicides)IBA
06/2014
1Fibronectins (Fibronectin)IBA
04/2014
1LipidsIBA
04/2014
1Interleukin-6 (Interleukin 6)IBA
09/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2013
1E-SelectinIBA
09/2013
1Interleukin-22 (IL-22)IBA
03/2013
1Interleukin-17 (Interleukin 17)IBA
03/2013
1Lactate Dehydrogenase 5IBA
01/2013
1ChlorhexidineIBA
10/2012
1PolyelectrolytesIBA
08/2012
1Proteins (Proteins, Gene)FDA Link
01/2011
1AntigensIBA
01/2011
1EpitopesIBA
01/2011
1Ointments (Pastes)IBA
02/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009
1Interleukin-1 (Interleukin 1)IBA
10/2009
1Messenger RNA (mRNA)IBA
10/2009
1Adenosine Triphosphate (ATP)IBA
09/2009
1ExotoxinsIBA
11/2008
1EndotoxinsIBA
02/2008
1SuspensionsIBA
03/2005
1leukotoxinIBA
12/2004
1VaccinesIBA
12/2004
1Loperamide (Imodium)FDA LinkGeneric
08/2003
1Omeprazole (Prilosec)FDA LinkGeneric
08/2003
1Cimetidine (Biomet)FDA LinkGeneric
08/2003
1Pentobarbital (Nembutal)FDA Link
08/2003
1SodiumIBA
08/2003
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
08/2002

Therapy/Procedure

2Biological Dressings
10/2012 - 08/2012
1Anesthesia
08/2003